Gland Pharma Limited IPO (Gland Pharma IPO) Detail

Nov 9, 2020 - Nov 11, 2020

Gland Pharma Ltd, the Hyderabad-based company is one of the fastest-growing generic injectable companies. It manufactures a diversified range of high-quality complex injectables. The company offers products like sterile injectables, oncology, and ophthalmics, complex injectables (peptides, suspensions, hormonal products, long-acting injectables), NCE-1s, First-to-File products, etc.

The company follows a B2B model to sell its products in more than 60 countries including the US, Canada, Australia, India, Europe, etc. Leading pharma companies i.e. Sagent Pharmaceuticals, Apotex Inc. Athnex Pharmaceutical Division, LLC, Fresenius Kabi USA, LLC, etc. are some of the key customers.

It has 7 robust manufacturing units in India comprising 4 finished formulations facilities, 22 production lines, and 3 APIs.

Company Strengths

  • The extensive product portfolio of complex injectables.
  • Diversified B2B model with a targeted B2C model in India.
  • Strong manufacturing capabilities.
  • Robust financial track record.
  • Experienced and qualified managerial team.

Company Promoters:

Fosun Pharma Industrial Pte. Ltd and Shanghai Fosun Pharmaceutical (Group) Co. Ltd is the company promoters.

Company Financials:

Summary of financial Information (Restated Consolidated)
Particulars For the year/period ended (₹ in million)
30-June-20 31-Mar-20 31-Mar-19 31-Mar-18
Total Assets 46,912.65 40,860.39 35,235.49 29,294.68
Total Revenue 9,162.89 27,724.08 21,297.67 16,716.82
Profit After Tax 3,135.90 7,728.58 4,518.56 3,210.51

Objects of the Issue:

The net proceeds from the IPO will be used for the following purposes:

  1. To finance the incremental working capital requirements of our Company
  2. To meet funding requirements for capital expenditure requirements
  3. To meet the general corporate purposes

Gland Pharma IPO Details

IPO DateNov 9, 2020 - Nov 11, 2020
Issue TypeBook Built Issue IPO
Issue Size43,196,968 Eq Shares of ₹1
(aggregating up to ₹6,479.55 Cr)
Fresh Issue8,333,333 Eq Shares of ₹1
(aggregating up to ₹1,250.00 Cr)
Offer for Sale34,863,635 Eq Shares of ₹1
(aggregating up to ₹5,229.55 Cr)
Face Value₹1 per equity share
IPO Price₹1490 to ₹1500 per equity share
Market Lot10 Shares
Min Order Quantity10 Shares
Listing AtBSE, NSE

Gland Pharma IPO Tentative Date / Timetable

Bid/Offer Opens OnNov 9, 2020
Bid/Offer Closes OnNov 11, 2020
Finalisation of Basis of AllotmentNov 17, 2020
Initiation of RefundsNov 18, 2020
Credit of Shares to Demat AcctNov 19, 2020
IPO Shares Listing DateNov 20, 2020

Gland Pharma IPO Lot Size and Price (Retail)

ApplicationLotsSharesAmount (Cut-off)

Gland Pharma IPO Promoter Holding

Pre Issue Share Holding74%
Post Issue Share Holding58%

Related Articles

Gland Pharma IPO Subscription Status (Bidding Detail)


Nov 11, 2020 18:00





Gland Pharma IPO Prospectus

Gland Pharma IPO Rating

Rating:Rated 3.3 stars

Vote Here ...

Gland Pharma IPO Listing Date

Listing DateFriday, November 20, 2020
BSE Script Code543245
Listing InB
IPO Price₹1500 per equity share
Face Value₹1 per equity share

Listing Day Trading Information

IPO Price
Last Trade

Company Contact Information

Gland Pharma Limited
Sy. No. 143 - 148, 150 and 151,
Near Gandi Maisamma 'X' Roads, D.P. Pally,Dundigal
Medchal-Malkajgiri District, Hyderabad

Phone: +91 40 3051 0999

Gland Pharma IPO Registrar

Link Intime India Private Ltd
   Link Intime India Private Ltd
   C 101, 247 Park, L.B.S.Marg,
   Vikhroli (West), Mumbai - 400083

Phone: +91-22-4918 6270

Gland Pharma IPO FAQs

  1. What is Gland Pharma IPO?

    Gland Pharma IPO is a main-board IPO of 43,196,968 equity shares of the face value of ₹1 aggregating up to ₹6,479.55 Crores. The issue is priced at ₹1490 to ₹1500 per equity share. The minimum order quantity is 10 Shares.

    The IPO opens on Nov 9, 2020, and closes on Nov 11, 2020.

    Link Intime India Private Ltd is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.

  2. How to apply in Gland Pharma IPO through Zerodha?

    Zerodha customers can apply online in Gland Pharma IPO using UPI as a payment gateway. Zerodha customers can apply in Gland Pharma IPO by login into Zerodha Console (back office) and submitting an IPO application form.

    Steps to apply in Gland Pharma IPO through Zerodha

    1. Visit the Zerodha website and login to Console.
    2. Go to Portfolio and click the IPOs link.
    3. Go to the 'Gland Pharma IPO' row and click the 'Bid' button.
    4. Enter your UPI ID, Quantity, and Price.
    5. ‘Submit’ IPO application form.
    6. Visit the UPI App (net banking or BHIM) to approve the mandate.

    Visit Zerodha IPO Application Process Review for more detail.

  3. When Gland Pharma IPO will open?

    The Gland Pharma IPO opens on Nov 9, 2020 and closes on Nov 11, 2020.

  4. What is the lot size of Gland Pharma IPO?

    Gland Pharma IPO lot size is 10 Shares and the minimum order quantity is 10 Shares.

  5. How to apply for Gland Pharma IPO?

    You can apply in Gland Pharma IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. Read more detail about apply IPO online through Zerodha, Upstox, 5Paisa, Edelweiss, ICICI Bank, HDFC Bank and SBI Bank.

  6. When Gland Pharma IPO allotment?

    The finalization of Basis of Allotment for Gland Pharma IPO will be done on Nov 17, 2020, and the allotted shares will be credited to your demat account by Nov 19, 2020. Check the Gland Pharma IPO allotment status.

  7. When is Gland Pharma IPO listing date?

    The Gland Pharma IPO listing date is on Friday, November 20, 2020.

Gland Pharma IPO Message Board

Ranked Members  Ranked Members

I Like It. | Report Abuse |

No Feedback Found. Be the first to post the comment.


Download Our Mobile App

Android App iOS App